glp-1/gip medication GLP-1 Medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 GIP Dual Agonist Injections
Description
Researchers continue to examine how GLP-1s might affect a persons health beyond type 2 diabetes management and weight loss

Oral semaglutide was found to provide a significantly greater reduction in HbA1c and body weight compared to empagliflozin at 52 weeks

We will also be sending notices to impacted members about their coverage and alternative options for wellness support

Clinicians can highlight ongoing research and reinforce the value of holistic health habits like diet, exercise, and cardiovascular risk managementall proven to protect cognitive function

Managing Potential Side Effects Like any medication, GLP-1s can cause side effects
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
[DOI] [PMC free article] [PubMed] [Google Scholar] 49.A heart disease study of semaglutide in patients with type 2 diabetes (SOUL)
